+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 929 Pages
  • Global
From
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 468 Pages
  • Global
From
Oral Typhoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Oral Typhoid Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 183 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 490 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 279 Pages
  • Global
From
Malaria Vaccines - Global Strategic Business Report - Product Thumbnail Image

Malaria Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 371 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 336 Pages
  • Global
From
Combination Vaccines - Global Strategic Business Report - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 373 Pages
  • Global
From
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 563 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • June 2025
  • 391 Pages
  • Global
From
From
From
From
Diabetic Foot Ulcer Market Report 2025 - Product Thumbnail Image

Diabetic Foot Ulcer Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
From
Loading Indicator